stoxline Quote Chart Rank Option Currency Glossary
  
QuidelOrtho Corporation (QDEL)
42.4  0.55 (1.31%)    05-24 16:00
Open: 41.84
High: 42.5
Volume: 785,195
  
Pre. Close: 41.85
Low: 41.26
Market Cap: 2,840(M)
Technical analysis
2024-05-24 4:55:16 PM
Short term     
Mid term     
Targets 6-month :  51.57 1-year :  55.78
Resists First :  44.15 Second :  47.75
Pivot price 42.99
Supports First :  38.33 Second :  31.89
MAs MA(5) :  42.11 MA(20) :  42.45
MA(100) :  51.63 MA(250) :  65.92
MACD MACD :  -0.1 Signal :  -0.2
%K %D K(14,3) :  26.4 D(3) :  29.9
RSI RSI(14): 48.9
52-week High :  89.11 Low :  37.77
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ QDEL ] has closed above bottom band by 34.5%. Bollinger Bands are 64.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 42.54 - 42.84 42.84 - 43.07
Low: 40.7 - 41.02 41.02 - 41.26
Close: 41.98 - 42.48 42.48 - 42.86
Company Description

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

Headline News

Fri, 24 May 2024
2024-05-24 | NDAQ:QDEL | Press Release | QuidelOrtho Corp - Stockhouse Publishing

Fri, 24 May 2024
QuidelOrtho (QDEL) Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws ... - GlobeNewswire

Fri, 24 May 2024
2024-05-24 | NDAQ:QDEL | Press Release | QuidelOrtho Corp - Stockhouse Publishing

Thu, 23 May 2024
QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference - Business Wire

Thu, 23 May 2024
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) should contact Levi ... - Longview News-Journal

Wed, 22 May 2024
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ... - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 67 (M)
Shares Float 51 (M)
Held by Insiders 1.4 (%)
Held by Institutions 104 (%)
Shares Short 3,130 (K)
Shares Short P.Month 2,250 (K)
Stock Financials
EPS -0.16
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 49.43
Profit Margin -61.7 %
Operating Margin 1.2 %
Return on Assets (ttm) 1.2 %
Return on Equity (ttm) -42.6 %
Qtrly Rev. Growth -16 %
Gross Profit (p.s.) 0
Sales Per Share 42.7
EBITDA (p.s.) 9.18
Qtrly Earnings Growth 0 %
Operating Cash Flow 280 (M)
Levered Free Cash Flow 197 (M)
Stock Valuations
PE Ratio -282.67
PEG Ratio 2.7
Price to Book value 0.85
Price to Sales 0.99
Price to Cash Flow 10.13
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android